TAF5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.700200E-01
Normal-vs-Stage2
3.163200E-01
Normal-vs-Stage3
6.785600E-02
Normal-vs-Stage4
7.452200E-01
Stage1-vs-Stage2
3.639700E-02
Stage1-vs-Stage3
4.223600E-02
Stage1-vs-Stage4
5.102400E-01
Stage2-vs-Stage3
9.118200E-02
Stage2-vs-Stage4
6.265600E-01
Stage3-vs-Stage4
1.625750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.458000E-01
Normal-vs-AfricanAmerican
7.803600E-01
Normal-vs-Asian
2.261800E-01
Caucasian-vs-AfricanAmerican
3.453600E-01
Caucasian-vs-Asian
6.479600E-01
AfricanAmerican-vs-Asian
1.529420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.865400E-01
Normal-vs-Female
4.322400E-01
Male-vs-Female
4.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.736600E-01
Normal-vs-Age(41-60Yrs)
5.007000E-01
Normal-vs-Age(61-80Yrs)
3.001400E-01
Normal-vs-Age(81-100Yrs)
3.125400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.207800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.194800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.436800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.467160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.892800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.088600E-01
Normal-vs-Daily Drinker
5.066200E-02
Normal-vs-Weekly Drinker
6.207200E-01
Normal-vs-Occasional Drinker
3.295600E-01
Normal-vs-Social Drinker
7.472200E-01
Non Drinker-vs-Daily Drinker
3.017000E-01
Non Drinker-vs-Weekly Drinker
5.296800E-01
Non Drinker-vs-Occasional Drinker
9.280000E-01
Non Drinker-vs-Social Drinker
1.612610E-01
Daily Drinker-vs-Weekly Drinker
2.333600E-01
Daily Drinker-vs-Occasional Drinker
3.763200E-01
Daily Drinker-vs-Social Drinker
5.968100E-02
Weekly Drinker-vs-Occasional Drinker
5.931000E-01
Weekly Drinker-vs-Social Drinker
6.953200E-01
Occasional Drinker-vs-Social Drinker
2.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.781600E-01
Normal-vs-Grade 2
8.683000E-01
Normal-vs-Grade 3
8.444800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.903000E-01
Grade 1-vs-Grade 3
6.270400E-01
Grade 1-vs-Grade 4
8.781600E-01
Grade 2-vs-Grade 3
6.775200E-01
Grade 2-vs-Grade 4
8.683000E-01
Grade 3-vs-Grade 4
8.444800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.750400E-01
Normal-vs-NonDiabetic
1.877990E-01
Diabetic-vs-NonDiabetic
5.331600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.528800E-01
Normal-vs-NoPancreatitis
2.503200E-01
Pancreatitis-vs-NoPancreatitis
6.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.714400E-01
Normal-vs-N1
3.110800E-01
N0-vs-N1
5.746400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.928200E-01
Normal-vs-TP53-NonMutant
9.660200E-01
TP53-Mutant-vs-TP53-NonMutant
5.577400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
